- Home
- VTOL vs IMTX Comparison
VTOL vs IMTX Comparison
Compare VTOL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VTOL | IMTX |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VTOL | IMTX |
|---|---|---|
| Price | $44.45 | $9.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $19.25 |
| AVG Volume (30 Days) | 192.6K | ★ 369.5K |
| Earning Date | 02-27-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 148.42 | N/A |
| EPS | ★ 4.78 | N/A |
| Revenue | ★ $1,466,774,000.00 | $99,445,031.00 |
| Revenue This Year | $7.31 | N/A |
| Revenue Next Year | $9.48 | $19.39 |
| P/E Ratio | $9.23 | ★ N/A |
| Revenue Growth | ★ 2.95 | N/A |
| 52 Week Low | $25.11 | $3.30 |
| 52 Week High | $46.04 | $12.41 |
Technical Indicators
Market Signals| Indicator | VTOL | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.43 | 50.34 |
| Support Level | $43.63 | $9.63 |
| Resistance Level | $46.04 | $10.42 |
| Average True Range (ATR) | 1.47 | 0.69 |
| MACD | -0.22 | 0.05 |
| Stochastic Oscillator | 32.76 | 64.50 |
Price Performance
Historical ComparisonAbout VTOL Bristow Group Inc.
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.